6.
Wang A, Chen C, Mei C, Liu S, Xiang C, Fang W
. Innate immune sensing of lysosomal dysfunction drives multiple lysosomal storage disorders. Nat Cell Biol. 2024; 26(2):219-234.
DOI: 10.1038/s41556-023-01339-x.
View
7.
Fu J, Kanne D, Leong M, Glickman L, McWhirter S, Lemmens E
. STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade. Sci Transl Med. 2015; 7(283):283ra52.
PMC: 4504692.
DOI: 10.1126/scitranslmed.aaa4306.
View
8.
Roers A, Hiller B, Hornung V
. Recognition of Endogenous Nucleic Acids by the Innate Immune System. Immunity. 2016; 44(4):739-54.
DOI: 10.1016/j.immuni.2016.04.002.
View
9.
Corrales L, Glickman L, McWhirter S, Kanne D, Sivick K, Katibah G
. Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity. Cell Rep. 2015; 11(7):1018-30.
PMC: 4440852.
DOI: 10.1016/j.celrep.2015.04.031.
View
10.
Luo W, Wang Y, Zhang L, Ren P, Zhang C, Li Y
. Critical Role of Cytosolic DNA and Its Sensing Adaptor STING in Aortic Degeneration, Dissection, and Rupture. Circulation. 2019; 141(1):42-66.
PMC: 6939474.
DOI: 10.1161/CIRCULATIONAHA.119.041460.
View
11.
Xiao Y, Zou Q, Xie X, Liu T, Li H, Jie Z
. The kinase TBK1 functions in dendritic cells to regulate T cell homeostasis, autoimmunity, and antitumor immunity. J Exp Med. 2017; 214(5):1493-1507.
PMC: 5413337.
DOI: 10.1084/jem.20161524.
View
12.
Gao D, Li T, Li X, Chen X, Li Q, Wight-Carter M
. Activation of cyclic GMP-AMP synthase by self-DNA causes autoimmune diseases. Proc Natl Acad Sci U S A. 2015; 112(42):E5699-705.
PMC: 4620884.
DOI: 10.1073/pnas.1516465112.
View
13.
Chan C, Liu X, Tang X, Fu H, Ye K
. Akt phosphorylation of zyxin mediates its interaction with acinus-S and prevents acinus-triggered chromatin condensation. Cell Death Differ. 2007; 14(9):1688-99.
DOI: 10.1038/sj.cdd.4402179.
View
14.
Marcus A, Mao A, Lensink-Vasan M, Wang L, Vance R, Raulet D
. Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response. Immunity. 2018; 49(4):754-763.e4.
PMC: 6488306.
DOI: 10.1016/j.immuni.2018.09.016.
View
15.
Sun Y, Revach O, Anderson S, Kessler E, Wolfe C, Jenney A
. Targeting TBK1 to overcome resistance to cancer immunotherapy. Nature. 2023; 615(7950):158-167.
PMC: 10171827.
DOI: 10.1038/s41586-023-05704-6.
View
16.
Davies L, Jenkins S, Allen J, Taylor P
. Tissue-resident macrophages. Nat Immunol. 2013; 14(10):986-95.
PMC: 4045180.
DOI: 10.1038/ni.2705.
View
17.
Yu C, Davidson S, Harapas C, Hilton J, Mlodzianoski M, Laohamonthonkul P
. TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS. Cell. 2020; 183(3):636-649.e18.
PMC: 7599077.
DOI: 10.1016/j.cell.2020.09.020.
View
18.
Samson N, Ablasser A
. The cGAS-STING pathway and cancer. Nat Cancer. 2022; 3(12):1452-1463.
DOI: 10.1038/s43018-022-00468-w.
View
19.
Chen S, Liu S, Wang J, Wu Q, Wang A, Guan H
. TBK1-Mediated DRP1 Targeting Confers Nucleic Acid Sensing to Reprogram Mitochondrial Dynamics and Physiology. Mol Cell. 2020; 80(5):810-827.e7.
DOI: 10.1016/j.molcel.2020.10.018.
View
20.
King K, Aguirre A, Ye Y, Sun Y, Roh J, Ng Jr R
. IRF3 and type I interferons fuel a fatal response to myocardial infarction. Nat Med. 2017; 23(12):1481-1487.
PMC: 6477926.
DOI: 10.1038/nm.4428.
View